Skinvisible, Inc. SEC filings SKVI
Skinvisible, Inc. has 391 filings in SEC EDGAR's recent list, going back to Apr 30, 1999. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jan 23, 2025 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| NT 10-Q | Notification of late filing | Nov 14, 2024 | Sep 30, 2024 |
| NT 10-Q | Extension | Aug 14, 2024 | Jun 30, 2024 |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| NT 10-Q | Filing | Nov 15, 2023 | Sep 30, 2023 |
| NT 10-Q | Filing | Nov 15, 2021 | Sep 30, 2021 |
| NT 10-Q | Filing | May 18, 2021 | Mar 31, 2021 |
| NT 10-K | Filing | Mar 29, 2021 | Dec 31, 2020 |
| NT 10-Q | Filing | Nov 16, 2020 | Sep 30, 2020 |
| NT 10-Q | Filing | Aug 14, 2020 | Jun 30, 2020 |
| NT 10-Q | Filing | Jun 29, 2020 | Mar 31, 2020 |
| NT 10-K | Filing | Mar 31, 2020 | Dec 31, 2019 |
| NT 10-Q | Filing | Nov 14, 2019 | Sep 30, 2019 |
| NT 10-Q | Filing | Aug 14, 2019 | Jun 30, 2019 |
| NT 10-Q | Filing | May 15, 2019 | Mar 31, 2019 |
| NT 10-K | Filing | Apr 1, 2019 | Dec 31, 2018 |
| UPLOAD | Letter from the SEC | Oct 12, 2018 | — |
| PRER14A | Filing | Oct 11, 2018 | — |
| PRER14A | Filing | Oct 5, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 1, 2018 | — |
| PRER14A | Filing | Sep 24, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2018 | — |
| PRER14A | Filing | Aug 28, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2018 | — |
| PRER14A | Filing | Jul 25, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 13, 2018 | — |
| PRER14A | Filing | Jul 6, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 20, 2018 | — |
| PRER14A | Filing | Jun 11, 2018 | — |
| UPLOAD | Letter from the SEC | May 30, 2018 | — |
| NT 10-Q | Filing | Aug 14, 2017 | Jun 30, 2017 |
| NT 10-K | Filing | Mar 30, 2017 | Dec 31, 2016 |
| NT 10-Q | Filing | Nov 14, 2016 | Sep 30, 2016 |
| NT 10-Q | Filing | Aug 15, 2016 | Jun 30, 2016 |
| NT 10-Q | Filing | May 16, 2016 | Mar 31, 2016 |
| NT 10-K | Filing | Mar 30, 2016 | Dec 31, 2015 |
| NT 10-K | Mainbody | Mar 28, 2014 | Dec 31, 2013 |
| NT 10-K | Mainbody | Apr 1, 2013 | Dec 31, 2012 |
| NT 10-Q | Mainbody | Nov 14, 2012 | Sep 30, 2012 |
| NT 10-K | Mainbody | Mar 29, 2012 | Dec 31, 2011 |
| NT 10-K | Mainbody | Mar 30, 2011 | Dec 31, 2010 |
| NT 10-K | Mainbody | Mar 30, 2010 | Dec 31, 2009 |
| NT 10-Q | Mainbody | Aug 14, 2009 | Jun 30, 2009 |
| NT 10-K | Mainbody | Mar 27, 2009 | Dec 31, 2008 |
| 10KSB | Mainbody | Apr 14, 2008 | Dec 31, 2007 |
| NT 10-K | Mainbody | Mar 28, 2008 | Dec 31, 2007 |
| 10QSB | Mainbody | Nov 14, 2007 | Sep 30, 2007 |
| 10QSB | Mainbody | Aug 14, 2007 | Jun 30, 2007 |
| 10QSB | Mainbody | May 15, 2007 | Mar 31, 2007 |
| 10KSB | Mainbody | Apr 2, 2007 | Dec 31, 2006 |
| 10QSB | Mainbody | Nov 14, 2006 | Sep 30, 2006 |
| 10QSB | Mainbody | Aug 16, 2006 | Jun 30, 2006 |
| NT 10-Q | Skinvisible, inc. nt 10-q mainbody | Aug 11, 2006 | Jun 30, 2006 |
| 10QSB | Skinvisible, inc. 10qsb mainbody | May 15, 2006 | Mar 31, 2006 |
| 10KSB | Skinvisible inc 10ksb mainbody | Mar 31, 2006 | Dec 31, 2005 |
| 10QSB | Skinvisible inc 10-qsb mainbody | Nov 15, 2005 | Sep 30, 2005 |
| NT 10-Q | Skinvisible inc nt 10-q mainbody | Nov 15, 2005 | Sep 30, 2005 |
| 10QSB | Mainbody | Aug 12, 2005 | Jun 30, 2005 |
| 10QSB | Mainbody | May 16, 2005 | Mar 31, 2005 |
| 10KSB | Skinvisible 10 ksb | Apr 14, 2005 | Dec 31, 2004 |
| NT 10-K | Skinvisible nt 10k | Mar 31, 2005 | Dec 31, 2004 |
| 10QSB | Skinvisible 10 qsb | Nov 15, 2004 | Sep 30, 2004 |
| 10QSB | Skinvisible 10 qsb | Aug 16, 2004 | Jun 30, 2004 |
| 10QSB | Skinvisible 10 qsb | May 17, 2004 | Mar 31, 2004 |
| 10KSB | Skinvisible 10ksb | Apr 14, 2004 | Dec 31, 2003 |
| NT 10-K | Skinvisible nt 10 k | Mar 31, 2004 | Dec 31, 2003 |
| 10QSB | Filing | Nov 19, 2003 | Sep 30, 2003 |
| NT 10-Q | Mainbody.html | Nov 14, 2003 | Sep 30, 2003 |
| 10QSB | Filing | Aug 14, 2003 | Jun 30, 2003 |
| 10QSB/A | Filing | May 22, 2003 | Mar 31, 2003 |
| REGDEX | Auto-generated paper document | May 19, 2003 | — |
| 10QSB | Filing | May 15, 2003 | Mar 31, 2003 |
| 10KSB/A | Filing | Apr 30, 2003 | Dec 31, 2002 |
| 10KSB | Filing | Mar 31, 2003 | Dec 31, 2002 |
| REGDEX | Auto-generated paper document | Nov 26, 2002 | — |
| 10QSB | Filing | Nov 14, 2002 | Sep 30, 2002 |
| 10QSB | Filing | May 15, 2002 | Mar 31, 2002 |
| 10KSB | Filing | Apr 12, 2002 | Dec 31, 2001 |
| NT 10-K | Filing | Apr 1, 2002 | Dec 31, 2001 |
| 10QSB | Filing | Nov 15, 2001 | Sep 30, 2001 |
| NT 10-Q | Filing | Nov 15, 2001 | Sep 30, 2001 |
| 10QSB | Filing | Aug 14, 2001 | Jun 30, 2001 |
| 10QSB | Filing | May 14, 2001 | Mar 31, 2001 |
| 10KSB | Filing | Apr 2, 2001 | Dec 31, 2000 |
| 10QSB | Filing | Nov 14, 2000 | Sep 30, 2000 |
| 10QSB | Filing | Aug 14, 2000 | Jun 30, 2000 |
| 10QSB | Filing | May 19, 2000 | Mar 31, 2000 |
| NT 10-Q | Filing | May 15, 2000 | Mar 31, 2000 |
| 10KSB/A | Filing | Apr 6, 2000 | Dec 31, 1999 |
| DEFR14A | Filing | Dec 13, 1999 | — |
| 10QSB | Filing | Nov 15, 1999 | Sep 30, 1999 |
| 10SB12G/A | Filing | Nov 8, 1999 | — |
| 10SB12G/A | Filing | Sep 14, 1999 | — |
| 10QSB | Filing | Aug 17, 1999 | Jun 30, 1999 |
| 10SB12G | Filing | Apr 30, 1999 | — |
Showing 95 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SKVI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1085277
- Former names
- SKINVISIBLE INC (until Aug 14, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.